Drug Repurposing News and Research

RSS
Drug repurposing offers hope for SYNGAP1 patients

Drug repurposing offers hope for SYNGAP1 patients

Groundbreaking discovery offers hope for patients suffering from toxic epidermal necrolysis

Groundbreaking discovery offers hope for patients suffering from toxic epidermal necrolysis

Harnessing the power of miRNA for cancer diagnosis and treatment

Harnessing the power of miRNA for cancer diagnosis and treatment

Differential gene expression linked to alcohol use disorder, offering new treatment possibilities

Differential gene expression linked to alcohol use disorder, offering new treatment possibilities

New deep-learning framework identifies non-addictive pain relief options

New deep-learning framework identifies non-addictive pain relief options

A randomized trial of mexiletine and lamotrigine in adults with non-dystrophic myotonia

A randomized trial of mexiletine and lamotrigine in adults with non-dystrophic myotonia

TxGNN improves drug repurposing by predicting treatments for rare diseases with no approved therapies

TxGNN improves drug repurposing by predicting treatments for rare diseases with no approved therapies

New AI tool revolutionizes drug discovery for rare diseases

New AI tool revolutionizes drug discovery for rare diseases

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

Existing drug shows promise for treating common liver disease

Existing drug shows promise for treating common liver disease

Repurposing pemafibrate to treat liver disease associated with metabolic disorders

Repurposing pemafibrate to treat liver disease associated with metabolic disorders

Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

Integration of genomics, epigenomics, and transcriptomics in understanding Alzheimer's pathogenesis

Integration of genomics, epigenomics, and transcriptomics in understanding Alzheimer's pathogenesis

New understanding of cancer drug's ability to prevent fat buildup in the liver

New understanding of cancer drug's ability to prevent fat buildup in the liver

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Drug repurposing study finds lonafarnib effective against RSV

Drug repurposing study finds lonafarnib effective against RSV

Study identifies more than 200 new genes linked to depression

Study identifies more than 200 new genes linked to depression

Deep learning unlocks new antibiotic classes, revolutionizing the fight against resistance

Deep learning unlocks new antibiotic classes, revolutionizing the fight against resistance

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.